Donor derived hematopoietic stem cell niche transplantation facilitates mixed chimerism mediated donor specific tolerance

被引:3
|
作者
Zhang, Wensheng [1 ,2 ]
Wang, Yong [1 ,2 ]
Zhong, Fushun [3 ]
Wang, Xinghuan [3 ]
Sucher, Robert [4 ]
Lin, Cheng-Hung [5 ]
Brandacher, Gerald [6 ]
Solari, Mario G. G. [1 ,2 ]
Gorantla, Vijay S. S. [7 ]
Zheng, Xin Xiao [1 ,3 ]
机构
[1] Univ Pittsburgh, Dept Plast Surg, Sch Med, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Thomas E Starzl Transplantat Inst, Sch Med, Pittsburgh, PA USA
[3] Wuhan Univ, Transplantat Med Ctr, Zhongnan Hosp, Wuhan, Hubei, Peoples R China
[4] Univ Hosp Leipzig, Dept Visceral Transplant Thorac & Vasc Surg, Leipzig, Germany
[5] Chang Gung Univ, Chang Gung Mem Hosp, Ctr Vascularized Composite Allotransplantat, Dept Plast & Reconstruct Surg,Coll Med, Tao Yuan, Taiwan
[6] Johns Hopkins Univ, Dept Plast & Reconstruct Surg, Vascularized Composite Allotransplantat Lab, Sch Med, Baltimore, MD USA
[7] Wake Forest Sch Med, Inst Regenerat Med, Dept Surg Ophthalmol & Bioengn, Winston Salem, NC USA
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
中国国家自然科学基金;
关键词
tolerance; vascularized composite allotransplantation; mixed chimerism; bone marrow transplantation; hematopoietic stem cell niche; thymic central deletion; BONE-MARROW-TRANSPLANTATION; COSTIMULATORY BLOCKADE; DENDRITIC CELLS; ALLOGRAFT TOLERANCE; CLONAL DELETION; SPLEEN COLONY; ENGRAFTMENT; INDUCTION; LEADS; MAINTENANCE;
D O I
10.3389/fimmu.2023.1093302
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Compelling experimental evidence confirms that the robustness and longevity of mixed chimerism (MC) relies on the persistence and availability of donor-derived hematopoietic stem cell (HSC) niches in recipients. Based on our prior work in rodent vascularized composite allotransplantation (VCA) models, we hypothesize that the vascularized bone components in VCA bearing donor HSC niches, thus may provide a unique biologic opportunity to facilitate stable MC and transplant tolerance. In this study, by utilizing a series of rodent VCA models we demonstrated that donor HSC niches in the vascularized bone facilitate persistent multilineage hematopoietic chimerism in transplant recipients and promote donor-specific tolerance without harsh myeloablation. In addition, the transplanted donor HSC niches in VCA facilitated the donor HSC niches seeding to the recipient bone marrow compartment and contributed to the maintenance and homeostasis of stable MC. Moreover, this study provided evidences that chimeric thymus plays a role in MC-mediated transplant tolerance through a mechanism of thymic central deletion. Mechanistic insights from our study could lead to the use of vascularized donor bone with pre-engrafted HSC niches as a safe, complementary strategy to induce robust and stable MC-mediated tolerance in VCA or solid organ transplantation recipients.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Evidence of donor derived malignancies following hematopoietic stem cell transplantation.
    Sala-Torra, O
    Loken, MR
    Flowers, MED
    Ladne, PA
    Mason, J
    Senitzer, D
    Forman, SJ
    Radich, J
    BLOOD, 2004, 104 (11) : 618A - 618A
  • [32] Tolerance Induction in HLA Disparate Living Donor Kidney Transplantation by Donor Stem Cell Infusion: Durable Chimerism Predicts Outcome
    Leventhal, Joseph
    Abecassis, Michael
    Miller, Joshua
    Gallon, Lorenzo
    Tollerud, David
    Elliott, Mary Jane
    Bozulic, Larry D.
    Houston, Christopher
    Sustento-Reodica, Nedjema
    Ildstad, Suzanne T.
    TRANSPLANTATION, 2013, 95 (01) : 169 - 176
  • [33] Transplanting across a donor specific HLA antibody in hematopoietic stem cell transplantation
    Edwards, Zdenka
    Frater, Sandra
    Peat, James
    Fernando, Raymond
    Walsh, Lisa
    Vivers, Sharon
    HLA, 2023, 101 (04) : 394 - 395
  • [34] Efficacy of donor lymphocyte infusions for persistent mixed chimerism following haematopoetic stem cell transplantation
    Braybrook, Henry
    Davies, David
    Wilson, Keith
    Kempshall, Emma
    Ingram, Wendy
    BONE MARROW TRANSPLANTATION, 2019, 54 : 488 - 488
  • [35] Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor - Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts
    Leventhal, Joseph R.
    Galvin, John P.
    Mathew, James
    Gallon, Lorenzo
    Ravindra, Kadiyala
    Horwitz, Mitchell E.
    Abecassis, Michael
    Ildstad, Suzanne T.
    BLOOD, 2018, 132
  • [36] Correlation of donor chimerism and outcomes in children with severe aplastic anemia after hematopoietic stem cell transplantation
    Crowell, S.
    Abu-Arja, R.
    Rangarajan, H.
    Pai, V.
    Stanek, J.
    Bajwa, R.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 125 - 126
  • [37] Systematic comparison of donor chimerism in peripheral blood and bone marrow after hematopoietic stem cell transplantation
    C Bach
    M Steffen
    W Roesler
    J Winkler
    A Mackensen
    K-D Stachel
    M Metzler
    B M Spriewald
    Blood Cancer Journal, 2017, 7 : e566 - e566
  • [38] Systematic comparison of donor chimerism in peripheral blood and bone marrow after hematopoietic stem cell transplantation
    Bach, C.
    Steffen, M.
    Roesler, W.
    Winkler, J.
    Mackensen, A.
    Stachel, K-D
    Metzler, M.
    Spriewald, B. M.
    BLOOD CANCER JOURNAL, 2017, 7 : e566 - e566
  • [39] OUTCOMES AFTER DONOR LYMPHOCYTE INFUSION FOR INSUFFICIENT DONOR CHIMERISM FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NON-MALIGNANT DISORDERS
    Biewen, Carter
    Smith, Angela
    Tolar, Jakub
    Miller, Weston
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S99 - S100
  • [40] Donor leukocyte infusions after unrelated donor hematopoietic stem cell transplantation
    Loren, AW
    Porter, DL
    CURRENT OPINION IN ONCOLOGY, 2006, 18 (02) : 107 - 114